Englander Institute for Precision Medicine

Publications

Found 805 results
Author Title Type [ Year(Asc)]
2022
Cuppen E, Elemento O, Rosenquist R, Nikic S, IJzerman M, Zaleski IDurand, Frederix G, Levin L-Å, Mullighan CG, Buettner R et al..  2022.  Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care.. JCO Precis Oncol. 6:e2200245.
Kindt A, Kraus Y, Rasp D, Foerster KM, Ahmidi N, Flemmer AW, Herber-Jonat S, Heinen F, Weigand H, Hankemeier T et al..  2022.  Improved Macro- and Micronutrient Supply for Favorable Growth and Metabolomic Profile with Standardized Parenteral Nutrition Solutions for Very Preterm Infants.. Nutrients. 14(19)
Argueta LB, Lacko LA, Bram Y, Tada T, Carrau L, Rendeiro AFigueiredo, Zhang T, Uhl S, Lubor BC, Chandar V et al..  2022.  Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy.. iScience. 25(5):104223.
Raman R, Villefranc JA, Ullmann TM, Thiesmeyer J, Anelli V, Yao J, Hurley JR, Pauli C, Bareja R, Eng KWha et al..  2022.  Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.. J Exp Med. 219(6)
Buyukozkan M, Alvarez-Mulett S, Racanelli AC, Schmidt F, Batra R, Hoffman KL, Sarwath H, Engelke R, Gomez-Escobar L, Simmons W et al..  2022.  Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19.. iScience. 25(7):104612.
Horgusluoglu E, Neff R, Song W-M, Wang M, Wang Q, Arnold M, Krumsiek J, Galindo-Prieto B, Ming C, Nho K et al..  2022.  Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.. Alzheimers Dement. 18(6):1260-1278.
He Y, Kim I-K, Bian J, Polyzos A, Di Giammartino DCampigli, Zhang Y-W, Luo J, Hernandez MO, Kedei N, Cam M et al..  2022.  A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.. J Thorac Oncol. 17(12):1375-1386.
Linares JF, Cid-Diaz T, Duran A, Osrodek M, Martinez-Ordoñez A, Reina-Campos M, Kuo H-H, Elemento O, M Martin L, Cordes T et al..  2022.  The lactate-NAD axis activates cancer-associated fibroblasts by downregulating p62.. Cell Rep. 39(6):110792.
Batra R, Arnold M, Wörheide MA, Allen M, Wang X, Blach C, Levey AI, Seyfried NT, Ertekin-Taner N, Bennett DA et al..  2022.  The landscape of metabolic brain alterations in Alzheimer's disease.. Alzheimers Dement.
Arora H, Qureshi R, Khodamoradi K, Seetharam D, Parmar M, Van Booven DJ, Issa ICatherine, Sackstein R, Lamb D, Hare JM et al..  2022.  Leptin secreted from testicular microenvironment modulates hedgehog signaling to augment the endogenous function of Leydig cells.. Cell Death Dis. 13(3):208.
Liu W, Faltas BM.  2022.  Loss of function mutations in are permissive for APOBEC3-induced mutagenesis in urothelial carcinoma.. Am J Cancer Res. 12(5):2419-2421.
Le Naour J, Sztupinszki Z, Carbonnier V, Casiraghi O, Marty V, Galluzzi L, Szallasi Z, Kroemer G, Vacchelli E.  2022.  A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients.. Oncoimmunology. 11(1):2059878.
Summers BD, Kim K, Clement CC, Khan Z, Thangaswamy S, McCright J, Maisel K, Zamora S, Quintero S, Racanelli AC et al..  2022.  Lung lymphatic thrombosis and dysfunction caused by cigarette smoke exposure precedes emphysema in mice.. Sci Rep. 12(1):5012.
Gillessen S, Armstrong A, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Bulbul M et al..  2022.  Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.. Eur Urol. 82(1):115-141.
Chetnik K, Benedetti E, Gomari DP, Schweickart A, Batra R, Buyukozkan M, Wang Z, Arnold M, Zierer J, Suhre K et al..  2022.  maplet: an extensible R toolbox for modular and reproducible metabolomics pipelines.. Bioinformatics. 38(4):1168-1170.
Tombal B, Sternberg CN, Hussain M, Ganguli A, Li Y, Sandin R, Bhadauria H, Oh M, Saad F.  2022.  Matching-adjusted indirect treatment comparison of the efficacy of enzalutamide versus apalutamide for the treatment of nonmetastatic castration-resistant prostate cancer.. ESMO Open. 7(3):100510.
Jiménez-Cortegana C, Galassi C, Galluzzi L.  2022.  MDSCs sneak CSCs out of (immuno)surveillance.. Trends Immunol. 43(1):1-3.
Greenberg J, Limberg J, Verma A, Kim D, Chen X, Lee YJ, Moore MD, Ullmann TM, Thiesmeyer JW, Loewenstein Z et al..  2022.  Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration.. JCI Insight. 7(23)
Ferrara CR, Bai JDong K, McNally EM, Putzel GG, Zhou XKathy, Wang H, Lang A, Nagle D, Denoya P, Krumsiek J et al..  2022.  Microbes Contribute to Chemopreventive Efficacy, Intestinal Tumorigenesis, and the Metabolome.. Cancer Prev Res (Phila). 15(12):803-814.
Ganly I, Liu EMinwei, Kuo F, Makarov V, Dong Y, Park J, Gong Y, Gorelick AN, Knauf JA, Benedetti E et al..  2022.  Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma.. Sci Adv. 8(25):eabn9699.
Ruthig VA, Lamb DJ.  2022.  Modeling development of genitourinary birth defects to understand disruption due to changes in gene dosage.. Am J Clin Exp Urol. 10(6):412-424.
Martinez-Fundichely A, Dixon A, Khurana E.  2022.  Modeling tissue-specific breakpoint proximity of structural variations from whole-genomes to identify cancer drivers.. Nat Commun. 13(1):5640.
Ertl IE, Lemberger U, Ilijazi D, Hassler MR, Bruchbacher A, Brettner R, Kronabitter H, Gutmann M, Vician P, Zeitler G et al..  2022.  Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.. Eur Urol. 82(3):261-270.
Santambrogio L.  2022.  Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome.. Front Immunol. 13:878271.
Cai PY, Asad M, Augello MA, Martin L, Louie C, Basourakos SP, Gaffney CD, Shoag J, Tu JJenny, Khani F et al..  2022.  A multidisciplinary approach to optimize primary prostate cancer biobanking.. Urol Oncol. 40(6):271.e1-271.e7.